Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim continuation study in pediatric immune thrombocytopenia after completion of RMC 0235-14
MOH_2018-01-08_002075Phase 3Active, not recruiting
- Sponsor
- פרופ' חנה תמרי
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of romiplostim in immune thrombocytopenia (ITP), sponsored by פרופ' חנה תמרי. Primary endpoint: Not specified. Started Jan 2018; status: active, not recruiting.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on MOH_2018-01-08_002075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-01-08_002075.